CRISPR THERAPEUTICS AG Shares Outstanding (Cover Page)
CRISPR THERAPEUTICS AG (CRSP) had Shares Outstanding (Cover Page) of 96.69 million shares as of 2026-07-31, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-03
- 2026-07-31: Entity Common Stock, Shares Outstanding 96.69M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 96.45M shares.
- 2026-02-10: Entity Common Stock, Shares Outstanding 95.99M shares.
- 2025-11-06: Entity Common Stock, Shares Outstanding 95.30M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 96.69M shares 10-Q · filed 2026-08-03 |
| 2026-04-30 | 96.45M shares 10-Q · filed 2026-05-04 |
| 2026-02-10 | 95.99M shares 10-K · filed 2026-02-12 |
| 2025-11-06 | 95.30M shares 10-Q · filed 2025-11-10 |
| 2025-08-01 | 90.95M shares 10-Q · filed 2025-08-04 |
| 2025-05-02 | 86.36M shares 10-Q · filed 2025-05-06 |
| 2025-02-07 | 85.77M shares 10-K · filed 2025-02-11 |
| 2024-11-01 | 85.35M shares 10-Q · filed 2024-11-05 |
| 2024-08-01 | 85.17M shares 10-Q · filed 2024-08-05 |
| 2024-05-03 | 84.92M shares 10-Q · filed 2024-05-08 |
| 2024-02-16 | 80.28M shares 10-K · filed 2024-02-21 |
| 2023-11-02 | 79.43M shares 10-Q · filed 2023-11-06 |
| 2023-08-03 | 79.41M shares 10-Q · filed 2023-08-07 |
| 2023-05-05 | 78.94M shares 10-Q · filed 2023-05-08 |
| 2023-02-16 | 78.65M shares 10-K · filed 2023-02-21 |
| 2022-10-28 | 78.29M shares 10-Q · filed 2022-11-01 |
| 2022-08-04 | 78.01M shares 10-Q · filed 2022-08-08 |
| 2022-05-05 | 77.46M shares 10-Q · filed 2022-05-09 |
| 2022-02-11 | 77.07M shares 10-K · filed 2022-02-15 |
| 2021-11-01 | 76.53M shares 10-Q · filed 2021-11-03 |
| 2021-07-27 | 76.20M shares 10-Q · filed 2021-07-29 |
| 2021-04-23 | 75.77M shares 10-Q · filed 2021-04-27 |
| 2021-02-11 | 75.43M shares 10-K · filed 2021-02-16 |
| 2020-10-23 | 70.65M shares 10-Q · filed 2020-10-28 |
| 2020-07-23 | 70.17M shares 10-Q · filed 2020-07-27 |
| 2020-04-24 | 61.02M shares 10-Q · filed 2020-04-28 |
| 2020-02-07 | 60.85M shares 10-K · filed 2020-02-12 |
| 2019-10-24 | 55.20M shares 10-Q · filed 2019-10-28 |
| 2019-07-25 | 54.66M shares 10-Q · filed 2019-07-29 |
| 2019-04-25 | 52.91M shares 10-Q · filed 2019-04-29 |
| 2019-02-21 | 52.28M shares 10-K · filed 2019-02-25 |
| 2018-11-01 | 51.90M shares 10-Q · filed 2018-11-07 |
| 2018-08-01 | 47.59M shares 10-Q · filed 2018-08-07 |
| 2018-04-30 | 47.19M shares 10-Q · filed 2018-05-08 |
| 2018-02-28 | 46.98M shares 10-K · filed 2018-03-08 |
| 2017-11-03 | 41.02M shares 10-Q · filed 2017-11-08 |
| 2017-08-07 | 40.59M shares 10-Q · filed 2017-08-10 |
| 2017-05-08 | 40.00M shares 10-Q · filed 2017-05-11 |
| 2017-03-01 | 39.81M shares 10-K · filed 2017-03-10 |
| 2016-11-21 | 39.81M shares 10-Q · filed 2016-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |